Supplement
Black seed is the seed of Nigella sativa, a flowering plant, and it contains thymoquinone, a compound studied for its antioxidant and anti-inflammatory activity. People most often look at it for hay fever, where the evidence is strongest: a trial of 257 people found allergy symptoms improved. That rests on a single study, though, and other findings, such as blood sugar and blood pressure improvements, come with only moderate evidence.
Sources: PMID 20947211
- Updated
- How we grade
- 33 studies cited
- Best evidence
- Grade A
- Conditions studied
- 19
- Outcomes
- 111
- Graded outcomes
- 1764
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergy Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 257 people | ||
Studies that measured allergy symptoms | ||||||
| Asthma Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 152 people | ||
Studies that measured asthma symptoms | ||||||
| Immunity | Improves (the measure goes up) | 1 study | 39 people | |||
Studies that measured immunity | ||||||
| Cortisol | Changes; see studies | 152 people | ||||
| Nasal Congestion | Improves (the measure goes up) | 66 people | ||||
General Cardiovascular Health
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2 studies | 3,679 people | ||
Studies that measured blood glucose | ||||||
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 1,527 people | ||
Studies that measured blood pressure | ||||||
Type 2 Diabetes
- Blood glucose: improves
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2 studies | 737 people | ||
Studies that measured blood glucose | ||||||
| Total cholesterol | Changes; see studies | 4 studies | 325 people | |||
Studies that measured total cholesterol
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 405 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| C-Reactive Protein (CRP) | Changes; see studies | 1 study | 134 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 405 people | |||
Studies that measured high-density lipoprotein (hdl) | ||||||
| Body Mass Index (BMI) | Changes; see studies | 285 people | ||||
| HbA1c | Changes; see studies | 490 people | ||||
| Insulin | Changes; see studies | 246 people | ||||
| Insulin Resistance | Changes; see studies | 319 people | ||||
| Interleukin 6 | Changes; see studies | 156 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 591 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 364 people | ||||
| TNF-Alpha | Changes; see studies | 307 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 480 people | ||||
| Triglycerides | Changes; see studies | 405 people | ||||
Metabolic Syndrome
- Blood glucose: improves
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2 studies | 748 people | ||
Studies that measured blood glucose | ||||||
| Total cholesterol | Changes; see studies | 4 studies | 488 people | |||
Studies that measured total cholesterol
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 568 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| C-Reactive Protein (CRP) | Changes; see studies | 1 study | 727 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 568 people | |||
Studies that measured high-density lipoprotein (hdl) | ||||||
| HbA1c | Changes; see studies | 389 people | ||||
| Interleukin 6 | Changes; see studies | 156 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 591 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 364 people | ||||
| TNF-Alpha | Changes; see studies | 307 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 480 people | ||||
| Triglycerides | Changes; see studies | 568 people | ||||
High Blood Pressure
- Blood Pressure: improves
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 1,527 people | ||
Studies that measured blood pressure | ||||||
| Total cholesterol | Changes; see studies | 4 studies | 103 people | |||
Studies that measured total cholesterol
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 103 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| Heart Rate | Changes; see studies | 1 study | 103 people | |||
Studies that measured heart rate | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 103 people | |||
Studies that measured high-density lipoprotein (hdl) | ||||||
| Liver Enzymes | Changes; see studies | 103 people | ||||
| Proteinuria | Improves (the measure goes up) | 103 people | ||||
| Serum Albumin | Improves (the measure goes up) | 103 people | ||||
| Triglycerides | Changes; see studies | 103 people | ||||
| Uric Acid | Changes; see studies | 103 people | ||||
| Weight | Changes; see studies | 103 people | ||||
Chronic Kidney Disease (CKD)
- C-Reactive Protein (CRP): improves
- Interleukin 6: changes; see studies
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 727 people | ||
Studies that measured c-reactive protein (crp) | ||||||
| Interleukin 6 | Changes; see studies | 156 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 591 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 364 people | ||||
| TNF-Alpha | Changes; see studies | 307 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 480 people | ||||
Nonalcoholic Fatty Liver Disease (NAFLD)
- C-Reactive Protein (CRP): improves
- Interleukin 6: changes; see studies
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 727 people | ||
Studies that measured c-reactive protein (crp) | ||||||
| Interleukin 6 | Changes; see studies | 156 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 591 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 364 people | ||||
| TNF-Alpha | Changes; see studies | 307 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 480 people | ||||
High Cholesterol
- Blood glucose: improves
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
Weight Loss & Maintenance
- Blood glucose: improves
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2 studies | 117 people | ||
Studies that measured blood glucose | ||||||
| Total cholesterol | Changes; see studies | 4 studies | 117 people | |||
Studies that measured total cholesterol
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 117 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| Blood Pressure | Changes; see studies | 1 study | 117 people | |||
Studies that measured blood pressure | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 117 people | |||
Studies that measured high-density lipoprotein (hdl) | ||||||
| Food Intake | Changes; see studies | 117 people | ||||
| Kidney Function | Improves (the measure goes up) | 117 people | ||||
| Liver Enzymes | Changes; see studies | 117 people | ||||
| Triglycerides | Changes; see studies | 117 people | ||||
| Weight | Changes; see studies | 117 people | ||||
Asthma
- Allergy Symptoms: improves
- Lung Function: improves
- Asthma Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergy Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 29 people | ||
Studies that measured allergy symptoms | ||||||
| Lung Function | Improves (the measure goes up) | 2 studies | 29 people | |||
Studies that measured lung function | ||||||
| Asthma Symptoms | Changes; see studies | 1 study | 29 people | |||
Studies that measured asthma symptoms | ||||||
Rheumatoid Arthritis (RA)
- Pain: improves
- Rheumatoid Arthritis Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pain Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 40 people | ||
| Rheumatoid Arthritis Symptoms | Changes; see studies | 40 people | ||||
Cognitive Improvement
- Attention: improves
- Blood Pressure: changes; see studies
- Bilirubin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Attention Small Improvement | Improves (the measure goes up) | Small effect | 40 people | |||
| Blood Pressure | Changes; see studies | 1 study | 40 people | |||
Studies that measured blood pressure | ||||||
| Bilirubin | Changes; see studies | 40 people | ||||
| Cognition | Improves (the measure goes up) | 40 people | ||||
| Kidney Function | Improves (the measure goes up) | 40 people | ||||
| Memory | Improves (the measure goes up) | 40 people | ||||
| Processing Accuracy | Improves (the measure goes up) | 40 people | ||||
| Processing Speed | Improves (the measure goes up) | 40 people | ||||
| Working Memory | Improves (the measure goes up) | 40 people | ||||
Metabolic Health
- Adiponectin
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 39 people |
Bone Health
- Bone turnover markers
- Bone-specific Alkaline Phosphatase: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone turnover markers No effect | NoneNo effect | 34 people | ||||
| Bone-specific Alkaline Phosphatase | Improves (the measure goes up) | 1 study | 34 people |
Obesity
- Adiponectin
- Total cholesterol: changes; see studies
- Low-density lipoprotein (LDL): changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 39 people | ||||
| Total cholesterol | Changes; see studies | 4 studies | 39 people | |||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 39 people | |||
| Blood Pressure | Changes; see studies | 1 study | 39 people | |||
| C-Reactive Protein (CRP) | Changes; see studies | 1 study | 39 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 39 people | |||
| Appetite | Changes; see studies | 39 people | ||||
| Free Testosterone | Improves (the measure goes up) | 39 people | ||||
| Liver Enzymes | Changes; see studies | 39 people | ||||
| Triglycerides | Changes; see studies | 39 people | ||||
| Uric Acid | Changes; see studies | 39 people | ||||
| Weight | Changes; see studies | 39 people |
Hepatitis C
- Bilirubin
- Blood glucose: changes; see studies
- Red Blood Cell Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 30 people | ||||
| Blood glucose | Changes; see studies | 2 studies | 30 people | |||
| Red Blood Cell Count | Improves (the measure goes up) | 1 study | 30 people | |||
| HCV Viral Load | Improves (the measure goes up) | 30 people | ||||
| Liver Enzymes | Changes; see studies | 30 people | ||||
| Serum Albumin | Improves (the measure goes up) | 30 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 30 people |
Respiratory Health
- Lung Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Lung Function | Improves (the measure goes up) | 2 studies | 40 people |
Coronary Artery Disease (CAD)
- Vascular Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Vascular Function | Improves (the measure goes up) | 1 study | 146 people |
Epilepsy
- Seizure Frequency: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seizure Frequency | Changes; see studies | 1 study | 22 people |
Key findings
- Allergy SymptomsImproves (the measure goes down)
- Blood glucoseImproves (the measure goes down)
- Blood PressureImproves (the measure goes down)
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Black seed products, in the forms the graded studies used where we can match them.
- Grade A
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
33 studies from PubMed
- Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta-analysis of randomized controlled clinical trials
- Black Seed and Its Active Component Thymoquinone: Clinical Applications
- Nigella sativa and Thymoquinone: A Therapeutic Promise for COVID-19 and Beyond
- Nigella sativa for Diabetes Management: A Review of Clinical Studies
- Safety and Efficacy of Nigella sativa in Clinical Practice
- Nigella sativa (Black Seed): A Comprehensive Review of Its Biological Effects
- Anti-Inflammatory Properties of Nigella sativa: A Systematic Review
- Nigella sativa (Black Seed) and Blood Pressure: A Comprehensive Review
- Therapeutic Properties of Nigella sativa: A Clinical Review
- Therapeutic Effects of Nigella sativa in Metabolic Syndrome: A Review
- Antioxidant and Anti-Cancer Effects of Nigella sativa: Evidence from Clinical Trials
- Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses
- Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial
- Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis of randomized controlled trials.
- Endothelial Function Responses to Nigella sativa (Black Seed) Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers
- Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male
- Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients
- Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases
- Herbal treatment of allergic rhinitis: the use of Nigella sativa
- Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial
- The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients
- Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension
- Effects of Nigella sativa on outcome of hepatitis C in Egypt
- Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study
- Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus
- supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
- The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials.
- The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial
- Effect of Nigella sativa Consumption on Lipid Profile and Glycemic Index in Patients with Metabolic Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome
- The effect of thymoquinone on intractable pediatric seizures (pilot study)
- The Effect of Selected Herbal Medicines on Bone Turnover Markers: A Systematic Review and Meta-Analysis.